Diabetes drugs and cardio risks evaluated
Wednesday, December 17, 2008 - 15:56
in Health & Medicine
WASHINGTON, Dec. 17 (UPI) -- The U.S. Food and Drug Administration is recommending companies developing type 2 diabetes drugs and biologics evaluate the products' cardiovascular risks.